trending Market Intelligence /marketintelligence/en/news-insights/trending/FhmQttNv4BmtydX8oy5slw2 content esgSubNav
In This List

Report: Swiss medical device company Medacta plans IPO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Report: Swiss medical device company Medacta plans IPO

Medacta Group SA, a family-owned Swiss company developing orthopedic implants, is planning an IPO on the SIX Swiss Exchange, Reuters reported.

The planned IPO would be a secondary offering and is expected to close in the second quarter of 2019. The Siccardi family, which founded the company, is expected to retain control after the offer.

An over-allotment option is also planned on existing shares, Reuters said.

Credit Suisse and Morgan Stanley are acting as joint global coordinators for the IPO, while JP Morgan and UBS Investment Bank are the joint bookrunners for the offer. Rothschild was also appointed as independent financial adviser to the Swiss company.